том 8 издание 21 страницы 3617-3623

Practical synthesis of (S)-2-(4-fluorophenyl)-3-methylbutanoic acid, key building block for the calcium antagonist Mibefradil

Тип публикацииJournal Article
Дата публикации1997-11-01
SJR
CiteScore
Impact factor
ISSN09574166, 1362511X
Catalysis
Organic Chemistry
Inorganic Chemistry
Physical and Theoretical Chemistry
Краткое описание
A short, technically feasible route was developed for the synthesis of (S)2-(4-fluorophenyl)-3-methylbutanoic acid (S)- 2 with an overall yield of 80% starting from 4-fluorophenylacetic acid. Asymmetric hydrogenation of the easily accessible unsaturated acid 3 in the presence of ruthenium(II) carboxylato complexes containing chiral atropisomeric diphosphines afforded (S)- 2 in up to 94% ee. The ee of (S)- 2 was upgraded to 98% by crystallization of its sodium salt. The same protocol was also applied to the synthesis of (S)-2-(4-chlorophenyl)-3-methylbutanoic acid.
Найдено 
Найдено 

Топ-30

Журналы

1
2
3
Chemical Reviews
3 публикации, 8.82%
Advanced Synthesis and Catalysis
2 публикации, 5.88%
Organic Letters
2 публикации, 5.88%
Journal of the American Chemical Society
2 публикации, 5.88%
Organic and Biomolecular Chemistry
2 публикации, 5.88%
Organometallics
1 публикация, 2.94%
Journal of Molecular Catalysis B Enzymatic
1 публикация, 2.94%
Journal of Molecular Catalysis A Chemical
1 публикация, 2.94%
Tetrahedron Asymmetry
1 публикация, 2.94%
Topics in Catalysis
1 публикация, 2.94%
ChemInform
1 публикация, 2.94%
Journal of Organic Chemistry
1 публикация, 2.94%
Organic Process Research and Development
1 публикация, 2.94%
Journal of the Chemical Society Perkin Transactions 1
1 публикация, 2.94%
Chemical Society Reviews
1 публикация, 2.94%
Tetrahedron
1 публикация, 2.94%
Angewandte Chemie - International Edition
1 публикация, 2.94%
Angewandte Chemie
1 публикация, 2.94%
1
2
3

Издатели

2
4
6
8
10
American Chemical Society (ACS)
10 публикаций, 29.41%
Elsevier
7 публикаций, 20.59%
Wiley
6 публикаций, 17.65%
Royal Society of Chemistry (RSC)
4 публикации, 11.76%
Springer Nature
1 публикация, 2.94%
2
4
6
8
10
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
34
Поделиться
Цитировать
ГОСТ |
Цитировать
Crameri Y. et al. Practical synthesis of (S)-2-(4-fluorophenyl)-3-methylbutanoic acid, key building block for the calcium antagonist Mibefradil // Tetrahedron Asymmetry. 1997. Vol. 8. No. 21. pp. 3617-3623.
ГОСТ со всеми авторами (до 50) Скопировать
Crameri Y., Foricher J., Scalone M., Schmid R. Practical synthesis of (S)-2-(4-fluorophenyl)-3-methylbutanoic acid, key building block for the calcium antagonist Mibefradil // Tetrahedron Asymmetry. 1997. Vol. 8. No. 21. pp. 3617-3623.
RIS |
Цитировать
TY - JOUR
DO - 10.1016/S0957-4166(97)00498-9
UR - https://doi.org/10.1016/S0957-4166(97)00498-9
TI - Practical synthesis of (S)-2-(4-fluorophenyl)-3-methylbutanoic acid, key building block for the calcium antagonist Mibefradil
T2 - Tetrahedron Asymmetry
AU - Crameri, Yvo
AU - Foricher, Joseph
AU - Scalone, Michelangelo
AU - Schmid, R.
PY - 1997
DA - 1997/11/01
PB - Elsevier
SP - 3617-3623
IS - 21
VL - 8
SN - 0957-4166
SN - 1362-511X
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{1997_Crameri,
author = {Yvo Crameri and Joseph Foricher and Michelangelo Scalone and R. Schmid},
title = {Practical synthesis of (S)-2-(4-fluorophenyl)-3-methylbutanoic acid, key building block for the calcium antagonist Mibefradil},
journal = {Tetrahedron Asymmetry},
year = {1997},
volume = {8},
publisher = {Elsevier},
month = {nov},
url = {https://doi.org/10.1016/S0957-4166(97)00498-9},
number = {21},
pages = {3617--3623},
doi = {10.1016/S0957-4166(97)00498-9}
}
MLA
Цитировать
Crameri, Yvo, et al. “Practical synthesis of (S)-2-(4-fluorophenyl)-3-methylbutanoic acid, key building block for the calcium antagonist Mibefradil.” Tetrahedron Asymmetry, vol. 8, no. 21, Nov. 1997, pp. 3617-3623. https://doi.org/10.1016/S0957-4166(97)00498-9.